East Brunswick, NJ, United States of America

Lin Yan

USPTO Granted Patents = 30 

 

 

Average Co-Inventor Count = 5.3

ph-index = 8

Forward Citations = 342(Granted Patents)


Location History:

  • Cambridge, MA (US) (2002)
  • Princeton, NJ (US) (2004 - 2009)
  • Brunswick, NJ (US) (2014)
  • East Brunswick, NJ (US) (2006 - 2023)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
30 patents (USPTO):

Title: Innovations in Insulin Delivery: The Patents of Lin Yan

Introduction

Lin Yan, an accomplished inventor residing in East Brunswick, NJ, has made significant contributions to the field of pharmaceutical innovations, particularly in the realm of insulin delivery systems. With a remarkable portfolio of 29 patents, he has dedicated his career to developing novel solutions that improve patient outcomes in diabetes management.

Latest Patents

Two of Lin Yan's latest patents focus on advanced conjugate-based systems for controlled insulin delivery. The first patent details a novel system where an insulin molecule is conjugated through a framework to multiple ligands that include saccharides. This unique approach allows for a fatty chain to be linked exclusively to the insulin molecule, establishing a new paradigm in sustained insulin release. The second patent introduces insulin dimer-incretin conjugates, combining insulin dimers with peptides that exhibit incretin activity. These innovative formulations demonstrate enhanced pharmacokinetic and pharmacodynamic properties, potentially revolutionizing diabetes treatment.

Career Highlights

Throughout his career, Lin Yan has been associated with notable organizations such as Merck Sharp & Dohme Corporation and Bristol-Myers Squibb Company. His work in these renowned companies has enabled him to refine his research and contribute substantially to modern medicine, helping shape the future of diabetic care through innovative drug delivery methods.

Collaborations

In his endeavors, Lin Yan has collaborated with prominent colleagues including Pei Huo and Songnian Lin. These partnerships have enriched his research, combining diverse expertise to push the boundaries of what is possible in the innovation of insulin therapies and beyond.

Conclusion

Lin Yan's extensive patent portfolio and collaborative efforts underline his commitment to advancing medical science. His work in developing conjugate-based insulin delivery systems exemplifies how innovative thinking can lead to breakthroughs that transform lives. As the field of diabetes management continues to evolve, Lin Yan's contributions will undoubtedly remain influential in shaping future therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…